Kimura H - Search Results

1

Effect of benzalkonium chloride on transscleral drug delivery.

Okabe K, Kimura H, Okabe J, Kato A, Shimizu H, Ueda T, Shimada S, Ogura Y. Okabe K, et al. Among authors: kimura h. Invest Ophthalmol Vis Sci. 2005 Feb;46(2):703-8. doi: 10.1167/iovs.03-0934. Invest Ophthalmol Vis Sci. 2005. PMID: 15671302

2

Biodegradable intrascleral implant for sustained intraocular delivery of betamethasone phosphate.

Okabe J, Kimura H, Kunou N, Okabe K, Kato A, Ogura Y. Okabe J, et al. Among authors: kimura h. Invest Ophthalmol Vis Sci. 2003 Feb;44(2):740-4. doi: 10.1167/iovs.02-0375. Invest Ophthalmol Vis Sci. 2003. PMID: 12556407

3

Intraocular tissue distribution of betamethasone after intrascleral administration using a non-biodegradable sustained drug delivery device.

Okabe K, Kimura H, Okabe J, Kato A, Kunou N, Ogura Y. Okabe K, et al. Among authors: kimura h. Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2702-7. doi: 10.1167/iovs.02-0956. Invest Ophthalmol Vis Sci. 2003. PMID: 12766076

4

Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis.

Sakurai E, Nozaki M, Okabe K, Kunou N, Kimura H, Ogura Y. Sakurai E, et al. Among authors: kimura h. Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4845-52. doi: 10.1167/iovs.02-1228. Invest Ophthalmol Vis Sci. 2003. PMID: 14578407

5

Feasibility of drug delivery to the posterior pole of the rabbit eye with an episcleral implant.

Kato A, Kimura H, Okabe K, Okabe J, Kunou N, Ogura Y. Kato A, et al. Among authors: kimura h. Invest Ophthalmol Vis Sci. 2004 Jan;45(1):238-44. doi: 10.1167/iovs.02-1258. Invest Ophthalmol Vis Sci. 2004. PMID: 14691179

6

Suppression of laser-induced choroidal neovascularization by posterior sub-tenon administration of triamcinolone acetonide.

Kato A, Kimura H, Okabe K, Okabe J, Kunou N, Nozaki M, Ogura Y. Kato A, et al. Among authors: kimura h. Retina. 2005 Jun;25(4):503-9. doi: 10.1097/00006982-200506000-00017. Retina. 2005. PMID: 15933599

7

Ocular tissue distribution of betamethasone after anterior-episcleral, posterior-episcleral, and anterior-intrascleral placement of nonbiodegradable implants.

Okabe K, Kimura H, Okabe J, Ogura Y. Okabe K, et al. Among authors: kimura h. Retina. 2007 Jul-Aug;27(6):770-7. doi: 10.1097/IAE.0b013e31802ea591. Retina. 2007. PMID: 17621189

8

Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits.

Yasukawa T, Kimura H, Tabata Y, Miyamoto H, Honda Y, Ogura Y. Yasukawa T, et al. Among authors: kimura h. Graefes Arch Clin Exp Ophthalmol. 2002 Aug;240(8):672-8. doi: 10.1007/s00417-002-0484-9. Epub 2002 Jul 12. Graefes Arch Clin Exp Ophthalmol. 2002. PMID: 12192462

9

Drug delivery systems for vitreoretinal diseases.

Yasukawa T, Ogura Y, Tabata Y, Kimura H, Wiedemann P, Honda Y. Yasukawa T, et al. Among authors: kimura h. Prog Retin Eye Res. 2004 May;23(3):253-81. doi: 10.1016/j.preteyeres.2004.02.003. Prog Retin Eye Res. 2004. PMID: 15177203 Review.

10

Intraocular sustained drug delivery using implantable polymeric devices.

Yasukawa T, Ogura Y, Sakurai E, Tabata Y, Kimura H. Yasukawa T, et al. Among authors: kimura h. Adv Drug Deliv Rev. 2005 Dec 13;57(14):2033-46. doi: 10.1016/j.addr.2005.09.005. Epub 2005 Nov 2. Adv Drug Deliv Rev. 2005. PMID: 16263193 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,926 results

Search Page

Filters